• Je něco špatně v tomto záznamu ?

A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens

L. Bubendorf, E. Conde, F. Cappuzzo, R. Langfort, HU. Schildhaus, J. Votruba, Á. Concha-López, I. Esteban-Rodriguez, J. Feng, J. Devenport, C. Boyiddle, S. Morris, K. Trunzer, KM. Kerr

. 2020 ; 128 (12) : 928-938. [pub] 20200728

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc21011776

BACKGROUND: The diagnosis of advanced lung cancer is made with minimally invasive procedures. This often results in the availability of cytological material only for subtype determination and companion diagnostic testing, with the latter being technically and clinically validated on histological material only. Thus, the primary objective of the MO29978 clinical study was to assess programmed death ligand 1 (PD-L1) protein expression on cytology samples as surrogates for histology samples in patients with lung cancer. METHODS: Formalin-fixed, paraffin-embedded histological samples and cytological cell blocks from 190 patients were analyzed with immunohistochemical assays using the rabbit monoclonal anti-PD-L1 antibody clones SP142 and SP263. PD-L1 expression was quantified on both tumor cells (TC) and tumor-infiltrating immune cells (IC). Overall concordance, sensitivity, specificity, and accuracy, with a 1% cutoff used for both assays, were assessed for PD-L1 expression on TC and IC. RESULTS: In non-small cell lung cancer histology and cytology samples measured with the PD-L1 (SP142) antibody (n = 173), the intraclass correlation coefficients were 0.40 and 0.06 on TC and IC, respectively. With SP142 and SP263, accuracies of 74.1% for TC and 51.9% for IC and accuracies of 75.2% for TC and 61.2% for IC, respectively, were reported. CONCLUSIONS: Overall, this study has demonstrated that PD-L1 analysis on TC is feasible in cytological material, but quantification is challenging. Tumor tissue should be preferred over cell block cytology for PD-L1 immunohistochemical analysis unless laboratories have validated their cytology preanalytical approaches and demonstrated the comparability of histology and cytology for TC PD-L1 results.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21011776
003      
CZ-PrNML
005      
20210507101832.0
007      
ta
008      
210420s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/cncy.22324 $2 doi
035    __
$a (PubMed)32721105
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Bubendorf, Lukas $u Department of Pathology, University Hospital Basel, Basel, Switzerland
245    12
$a A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens / $c L. Bubendorf, E. Conde, F. Cappuzzo, R. Langfort, HU. Schildhaus, J. Votruba, Á. Concha-López, I. Esteban-Rodriguez, J. Feng, J. Devenport, C. Boyiddle, S. Morris, K. Trunzer, KM. Kerr
520    9_
$a BACKGROUND: The diagnosis of advanced lung cancer is made with minimally invasive procedures. This often results in the availability of cytological material only for subtype determination and companion diagnostic testing, with the latter being technically and clinically validated on histological material only. Thus, the primary objective of the MO29978 clinical study was to assess programmed death ligand 1 (PD-L1) protein expression on cytology samples as surrogates for histology samples in patients with lung cancer. METHODS: Formalin-fixed, paraffin-embedded histological samples and cytological cell blocks from 190 patients were analyzed with immunohistochemical assays using the rabbit monoclonal anti-PD-L1 antibody clones SP142 and SP263. PD-L1 expression was quantified on both tumor cells (TC) and tumor-infiltrating immune cells (IC). Overall concordance, sensitivity, specificity, and accuracy, with a 1% cutoff used for both assays, were assessed for PD-L1 expression on TC and IC. RESULTS: In non-small cell lung cancer histology and cytology samples measured with the PD-L1 (SP142) antibody (n = 173), the intraclass correlation coefficients were 0.40 and 0.06 on TC and IC, respectively. With SP142 and SP263, accuracies of 74.1% for TC and 51.9% for IC and accuracies of 75.2% for TC and 61.2% for IC, respectively, were reported. CONCLUSIONS: Overall, this study has demonstrated that PD-L1 analysis on TC is feasible in cytological material, but quantification is challenging. Tumor tissue should be preferred over cell block cytology for PD-L1 immunohistochemical analysis unless laboratories have validated their cytology preanalytical approaches and demonstrated the comparability of histology and cytology for TC PD-L1 results.
650    _2
$a monoklonální protilátky $x imunologie $7 D000911
650    _2
$a antigeny CD274 $x imunologie $x metabolismus $7 D060890
650    _2
$a nádorové biomarkery $x imunologie $x metabolismus $7 D014408
650    _2
$a nemalobuněčný karcinom plic $x diagnóza $x metabolismus $7 D002289
650    _2
$a cytodiagnostika $x metody $7 D003581
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $x metody $7 D007150
650    _2
$a mezinárodní agentury $7 D007390
650    _2
$a nádory plic $x diagnóza $x metabolismus $7 D008175
650    _2
$a prospektivní studie $7 D011446
650    _2
$a ROC křivka $7 D012372
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Conde, Esther $u Department of Pathology-Targeted Therapies Laboratory, HM Sanchinarro University Hospital-Biomedical Research Networking Center in Oncology (CIBERONC), Madrid, Spain
700    1_
$a Cappuzzo, Federico $u Department of Oncology and Hematology, AUSL Romagna-Ravenna, Ravenna, Italy
700    1_
$a Langfort, Renata $u Department of Pathology, National Institute of Tuberculosis, Warsaw, Poland
700    1_
$a Schildhaus, Hans-Ulrich $u Department of Pathology, University of Göttingen, Göttingen, Germany
700    1_
$a Votruba, Jiří $u Department of Tuberculosis and Respiratory Diseases, General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Concha-López, Ángel $u Department of Anatomical Pathology, University Hospital Complex A Coruña, A Coruña, Spain
700    1_
$a Esteban-Rodriguez, Isabel $u Department of Pathology, La Paz University Hospital, Madrid, Spain
700    1_
$a Feng, Janine $u Roche Tissue Diagnostics, Tucson, Arizona
700    1_
$a Devenport, Jenny $u F. Hoffmann-La Roche Ltd, Basel, Switzerland
700    1_
$a Boyiddle, Christine $u Roche Tissue Diagnostics, Tucson, Arizona
700    1_
$a Morris, Stefanie $u F. Hoffmann-La Roche Ltd, Basel, Switzerland
700    1_
$a Trunzer, Kerstin $u F. Hoffmann-La Roche Ltd, Basel, Switzerland
700    1_
$a Kerr, Keith M $u Department of Pathology, University of Aberdeen, Aberdeen, United Kingdom
773    0_
$w MED00001036 $t Cancer cytopathology $x 1934-6638 $g Roč. 128, č. 12 (2020), s. 928-938
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32721105 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507101832 $b ABA008
999    __
$a ok $b bmc $g 1650220 $s 1132155
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 128 $c 12 $d 928-938 $e 20200728 $i 1934-6638 $m Cancer cytopathology $n Cancer Cytopathol $x MED00001036
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace